Abstract
BackgroundOropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV-positive) is associated with better clinical outcomes than HPV-negative OPSCC. However, the clinical benefits of immunotherapy in patients with HPV-positive OPSCC...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have